North American Clinical Trials Network (NACTN)
The North American Clinical Trials Network (NACTN) works to bring promising therapies out of the laboratory and into clinical trials, in a manner that provides strong evidence of effectiveness and safety. By uniting experts across the country, NACTN is gathering valid, meaningful data to speed the delivery of new therapies to the community. NACTN supports a network of clinical centers as well as clinical coordinating, data management and pharmacology sites, all dedicated to establishing best practices in the care and treatment of spinal cord injury. In addition to translating discoveries from the lab into clinical studies, NACTN maintains a patient registry of information that is important to the design and testing of possible new treatments for SCI.
Find out more.